MCT1 disruption causes axonal dysfunction and neurodegeneration in cell and animal models and MCT1 levels have been found to be decreased in patients and mouse models of ALS [22, 23]. This evidence concerns the gene SLC16A1 and amyotrophic lateral sclerosis.